Screener Summaries Updates Institutions Sign In More Updates › Mergers & Acquisitions › VANI Mergers & Acquisitions · Oct 30, 2026
Vivani Medical says merger with ClearOne pending final regulatory approval VANI Vivani Medical, Inc.
Vivani Medical confirms that the closing of its definitive agreement to merge its subsidiary Cortigent into ClearOne remains subject to receiving final regulatory approval. The parties expect the transaction to close shortly after such approval is obtained, following an anticipated October 2026 timeline. Vivani Medical operates in the medical device industry.
More from Vivani Medical, Inc. Vivani Medical expects to price and close merger with ClearOne via subsidiary Cortigent in October 2026 Sep 16, 2026 Vivani Medical announced the successful dosing of all participants in its SLIM-1 Phase 1 clinical trial for NPM-139, a… Aug 6, 2026 Vivani Medical, Inc. presented at the Emerging Growth Conference in New York on July 15, 2026 Jul 16, 2026 Vivani Medical, Inc. entered into a definitive merger agreement on July 1, 2026, where its subsidiary Cortigent, Inc.… Jul 7, 2026 Vivani Medical, Inc. stockholders' 2thought: 2026 Annual Meeting results show the approval of the 2022 Amended Plan… Jun 30, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.